Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hoyer

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
Behavioural Brain Research|June 8, 2025
Investigating the effects of orexin receptor 1 antagonism on decision making under uncertaintyJeremy A Metha, Mathilde Bertheau, Carsten Murawski, et al.
British Journal of Pharmacology|February 3, 2019
Sex differences in mouse models of fear inhibition: Fear extinction, safety learning, and fear-safety discriminationJacob W Clark, Sean P A Drummond, Daniel Hoyer, et al.
British Journal of Pharmacology|March 24, 2004
Comparison of functional profiles at human recombinant somatostatin sst2 receptor: simultaneous determination of intracellular Ca2+ and luciferase expression in CHO-K1 cellsCaroline Nunn, Davide Cervia, Daniel Langenegger, et al.
European Journal of Pharmacology|April 12, 2003
Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonistsCaroline Nunn, Daniel Langenegger, Konstanze Hurth, et al.
The American Journal of Case Reports|October 11, 2021
Toxic Epidermal Necrolysis Caused by Allopurinol: A Serious but Still Underestimated Adverse ReactionDaniel Hoyer, Carlo Atti, Sebastian Nuding, et al.
Annual Review of Pharmacology and Toxicology|September 14, 2023
Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and DiseaseJarrah O-Z J Kron, Ryan J Keenan, Daniel Hoyer, et al.
Nature Reviews. Drug Discovery|December 5, 2003
Opportunities in somatostatin research: biological, chemical and therapeutic aspectsGisbert Weckbecker, Ian Lewis, Rainer Albert, et al.
The Journal of Invasive Cardiology|August 22, 2024
Transcoronary guidewire ablation with radiofrequency in a porcine animal modelKonstantin M Heinroth, Daniel Hoyer, Dirk Mahnkopf, et al.
Pharmacology & Therapeutics|July 29, 2017
Polymyxins for CNS infections: Pharmacology and neurotoxicityTony Velkov, Chongshan Dai, Giuseppe D Ciccotosto, et al.
Progress in Neurobiology|July 15, 2009
Somatostatin, Alzheimer's disease and cognition: an old story coming of age?Jacques Epelbaum, Jean-Louis Guillou, François Gastambide, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
Behavioural Brain Research|June 8, 2025
Investigating the effects of orexin receptor 1 antagonism on decision making under uncertaintyJeremy A Metha, Mathilde Bertheau, Carsten Murawski, et al.
British Journal of Pharmacology|February 3, 2019
Sex differences in mouse models of fear inhibition: Fear extinction, safety learning, and fear-safety discriminationJacob W Clark, Sean P A Drummond, Daniel Hoyer, et al.
British Journal of Pharmacology|March 24, 2004
Comparison of functional profiles at human recombinant somatostatin sst2 receptor: simultaneous determination of intracellular Ca2+ and luciferase expression in CHO-K1 cellsCaroline Nunn, Davide Cervia, Daniel Langenegger, et al.
European Journal of Pharmacology|April 12, 2003
Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonistsCaroline Nunn, Daniel Langenegger, Konstanze Hurth, et al.
The American Journal of Case Reports|October 11, 2021
Toxic Epidermal Necrolysis Caused by Allopurinol: A Serious but Still Underestimated Adverse ReactionDaniel Hoyer, Carlo Atti, Sebastian Nuding, et al.
Annual Review of Pharmacology and Toxicology|September 14, 2023
Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and DiseaseJarrah O-Z J Kron, Ryan J Keenan, Daniel Hoyer, et al.
Nature Reviews. Drug Discovery|December 5, 2003
Opportunities in somatostatin research: biological, chemical and therapeutic aspectsGisbert Weckbecker, Ian Lewis, Rainer Albert, et al.
The Journal of Invasive Cardiology|August 22, 2024
Transcoronary guidewire ablation with radiofrequency in a porcine animal modelKonstantin M Heinroth, Daniel Hoyer, Dirk Mahnkopf, et al.
Pharmacology & Therapeutics|July 29, 2017
Polymyxins for CNS infections: Pharmacology and neurotoxicityTony Velkov, Chongshan Dai, Giuseppe D Ciccotosto, et al.
Progress in Neurobiology|July 15, 2009
Somatostatin, Alzheimer's disease and cognition: an old story coming of age?Jacques Epelbaum, Jean-Louis Guillou, François Gastambide, et al.
Pageof 16